Search
for

    Sort by

    Research 181–210 of 1000+

    1. Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride PeerJ · 2017 · 50 citations
    2. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink BMJ · 2016 · 30 citations
    3. Erectile dysfunction: Is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence Frontiers in Reproductive Health · 2022 · 25 citations
    4. Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial The Journal of Urology · 2023 · 20 citations
    5. Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia The World Journal of Men's Health · 2018 · 20 citations
    6. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Hormone Molecular Biology and Clinical Investigation · 2017 · 20 citations
    7. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia Hormone Molecular Biology and Clinical Investigation · 2015 · 20 citations
    8. Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment The World Journal of Men s Health · 2018 · 17 citations
    9. COMPARISON OF FINASTERIDE AND ALPHA‐BLOCKERS AS INDEPENDENT RISK FACTORS FOR ERECTILE DYSFUNCTION International Journal of Clinical Practice · 2003 · 9 citations
    10. Shock Wave Therapy for Erectile Dysfunction: Marketing and Practice Trends in Major Metropolitan Areas in the United States Urology Practice · 2022 · 8 citations
    11. Developmental and functional roles of androgen and interactive signals for external genitalia and erectile tissues Reproductive Medicine and Biology · 2024 · 5 citations
    12. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    13. Erectile Dysfunction in Young Adults: A Narrative Review Cureus · 2025 · 1 citations
    14. Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database Expert Opinion on Drug Safety · 2024 · 1 citations
    15. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance British Journal of Clinical Pharmacology · 2021 · 1 citations
    16. Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · 2020 · 1 citations
    17. 311 Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia The Journal of Sexual Medicine · 2018 · 1 citations
    18. IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY The Journal of Urology · 2026
    19. Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis The Journal of Sexual Medicine · 2026
    20. The manosphere and men's health: unpacking the links between online communities, body dysmorphia and erectile dysfunction Journal of Men s Health · 2025
    21. Assessment of Serum Ischemia Modified Albumin Level and Erectile Functions in Individuals with Premature Greying of Hair Benha Journal of Applied Sciences · 2024
    22. (122) Erectile Hemodynamics Asessment In ED Patients With Self-Diagnosed Post-finasteride syndrome (PFS) The Journal of Sexual Medicine · 2023
    23. Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura Revista Chilena de Urología · 2023
    24. 310 Clinical Improvements in Erectile Function and Mood in Hypogonadal Men Treated with 4.5% Nasal Testosterone Gel (Natesto) The Journal of Sexual Medicine · 2018
    25. Testosterone is poorly related to erectile dysfunction in young/middle aged human immunodeficiency virus-infected men Endocrine Abstracts · 2017
    26. 332 Recognizing and Treating Undiagnosed Erectile Dysfunction (ED) in Patients Presenting With Lower Urinary Tract Symptoms (LUTS) ˜The œjournal of sexual medicine · 2016
    27. The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease Yearbook of Urology · 2013
    28. 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE The Journal of Urology · 2012
    29. 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients? Journal of Men's Health · 2010
    30. Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil Sexual Medicine Reviews · 2023